Translation Section


Introduction to haemostasis from a pharmacodynamic perspective
inline image

Cornelis Kluft & Jacobus Burggraaf

inline image

Inhibitors of the initiation of coagulation
inline image

Ilka Ott

inline image

Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice
inline image

Massimo Franchini & Pier Mannuccio Mannucci

inline image

Inhibitors of propagation of coagulation: factors V and X
inline image

Vincenzo Toschi & Maddalena Lettino

inline image

Direct thrombin inhibitors
inline image

Catherine J. Lee & Jack E. Ansell

inline image

New anticoagulants: how to deal with treatment failure and bleeding complications
inline image

Rashid S. Kazmi & Bashir A. Lwaleed

inline image

Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation
inline image

Gabriella Passacquale & Albert Ferro

inline image

Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy
inline image

Timothy D. Warner, Sven Nylander & Carl Whatling

inline image

Anti-platelet therapy: phosphodiesterase inhibitors
inline image

Paolo Gresele, Stefania Momi & Emanuela Falcinelli

inline image

Anti-platelet therapy: ADP receptor antagonists
inline image

Yanushi Dullewe Wijeyeratne & Stan Heptinstall

inline image

Antiplatelet therapy: thrombin receptor antagonists
inline image

Antonio Tello-Montoliu, Salvatore D. Tomasello, Masafumi Ueno & Dominick J. Angiolillo

inline image

Anti-platelet therapy: glycoprotein IIb-IIIa antagonists
inline image

David J. Schneider

inline image

Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations
inline image

Nalyaka Sambu & Nick Curzen

inline image

Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?
inline image

Terry K. W. Ma, Yat-Yin Lam, Victoria P. Tan & Bryan P. Yan

inline image

The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene
inline image

Patricia McGettigan, Lisa F. Lincz, John Attia, Patrick McElduff, Linda Bissett, Roseanne Peel, Barrie Stokes, Stephen Hancock, Kim Henderson, Michael Seldon & David Henry

inline image

Ancillary